4 takeaways from 23&Me’s planned SPAC deal

  • by

Consumer DNA testing company 23andMe plans to go public through a merger with a special-purpose acquisition company started by Virgin Group. As sales of DNA testing kits wane, how will 23andMe drum up new interest for its business?

Augmedix goes public through reverse merger

  • by

The company, which offers a remote scribe services, secured $25 million in private placement financing and began trading publicly on the OTC markets after a reverse merger with Malo Holdings.